Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

This site uses cookies to store information on your computer. Some cookies on this site are essential and the site won’t work as expected without them. To learn more about cookies and their benefits, please view our cookies policy. You could also decide what kind of cookie the website could use or not use on our cookies settings page.
By closing this message or navigating within the website, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.

Help menu :

  1. Sanofi Worldwide |
     
  2. Our UK Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Site map |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  
 
 

About Us

Content :

Growth platforms

September 26, 2011

Sanofi seeks growth by diversifying its activities and its worldwide presence. We have six growth platforms; emerging markets, human vaccines, consumer healthcare, diabetes treatment, innovative products and animal health.

 
  • Emerging markets - we are the leading healthcare company as a result of a long and strong heritage

  • Human vaccines - we have developed a strong pipeline and have the ability to respond to public health needs

  • Consumer healthcare - we are the fifth largest player globally

  • Diabetes treatment - our vision is to respond to all patients' healthcare needs, not just treatments, but innovative services and technology

  • Innovative products - developing innovative medicines is our core strength and we will continue to respond to future public health needs

  • Animal health - one of the world's leading companies dedicated to the research, development, manufacture and delivery of innovative pharmaceuticals and vaccines for animals

The world's healthcare needs cannot be met by a single type of therapy.  New products such as biotech-derived medicines, generics and vaccines will be our focus in finding and developing these new opportunities.

Alongside our portfolio of prescription medicines, we are strengthening our activities in other areas including vaccines, OTC consumer healthcare products, branded generics and services.  Worldwide, these are all adapted to each region, country and patient.

Our growth strategy is based on acquisitions and partnerships that create shareholder value by creating or reinforcing platforms for long-term growth.

Sanofi is committed to unleashing creativity and innovation by actively engaging with third parties.  The acquisitions of Zentiva, Medley, Kendricks, Acambis and Symbion Consumer, as well as Merial in animal health, are the first steps in this direction.

 

Module :

Corporate Information

Corporate Information

 

Sanofi In The UK

Sanofi in the UK

Find out more about Sanofi UK's business units and locations, our investment in research and development, and our product pipeline

 

Sustainability

Sustainability

Sanofi is respected as a global leader in healthcare, partly because of the benefits of our medicines and vaccines, and also because of the ethical way we engage with patients, customers, colleagues, suppliers and healthcare authorities.